Houssiau F A, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer J P, Renauld J C
Department of Rheumatology, UCL 5390, Bruxelles, Belgium.
Lupus. 1995 Oct;4(5):393-5. doi: 10.1177/096120339500400510.
We investigated whether serum titers of interleukin 10 (IL-10), a cytokine known to shift lymphocyte responses towards humoral immunity, reflect disease activity in systemic lupus erythematosus (SLE). Sera from 72 SLE patients, 25 RA patients and 30 healthy controls were tested for IL-10 by ELISA. Low titers of IL-10 were detected in the serum of 37.5% of SLE patients and in 24% of RA patients but in only 3% of healthy controls. Interestingly, serum IL-10 titers in SLE patients were positively correlated with the SLE Disease Activity Index (SLEDAI) and with anti-DNA antibody titers, but negatively with complement fraction C3 levels. These results indicate that serum IL-10 values reflect SLE disease activity and suggest that overexpression of IL-10 might play a pathogenic role in severe lupus disease.
我们研究了白细胞介素10(IL-10)的血清滴度是否反映系统性红斑狼疮(SLE)的疾病活动,IL-10是一种已知可使淋巴细胞反应转向体液免疫的细胞因子。通过ELISA检测了72例SLE患者、25例类风湿关节炎(RA)患者和30例健康对照者血清中的IL-10。37.5%的SLE患者血清中检测到低滴度的IL-10,24%的RA患者血清中检测到低滴度的IL-10,但仅3%的健康对照者血清中检测到低滴度的IL-10。有趣的是,SLE患者血清IL-10滴度与SLE疾病活动指数(SLEDAI)和抗DNA抗体滴度呈正相关,但与补体C3水平呈负相关。这些结果表明血清IL-10值反映SLE疾病活动,并提示IL-10的过度表达可能在严重狼疮疾病中起致病作用。